1. Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck

   • M. Rita I. Young

   Review 22 November 2003 Pages: 375 - 382

   

2. In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances

   • Ritsuko Ishii
   • Masumi Shimizu
   • Hidemi Takahashi

   Original Article 18 November 2003 Pages: 383 - 390

   

3. Identification of a MHC class-II restricted epitope in carcinoembryonic antigen

   • Lei Shen
   • Roland Schroers
   • Si-Yi Chen

   Original Article 18 November 2003 Pages: 391 - 403

   

4. Effect of albumin fusion on the biodistribution of interleukin-2

   • Zhengsheng Yao
   • Weili Dai
   • Cynthia Sung

   Original Article 18 November 2003 Pages: 404 - 410

   

5. Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies

   • Pamela J. Russell
   • Dean Hewish
   • Alexander A. Kortt

   Original Article 13 January 2004 Pages: 411 - 421

   

6. Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D₃

   • Deanne M. R. Lathers
   • Joseph I. Clark
   • M. Rita I. Young

   Original Article 26 November 2003 Pages: 422 - 430

   

7. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display

   • Alexander Fosså
   • Lene Alsøe
   • Erlend B. Smeland

   Original Article 28 January 2004 Pages: 431 - 438

   

8. Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell clones in vitro

   • Ida Aagård Hedfors
   • Jan E. Brinchmann

   Original Article 18 November 2003 Pages: 439 - 444

   

9. Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma

   • Halina Kusnierczyk
   • Elzbieta Pajtasz-Piasecka
   • Willem Den Otter

   Original Article 10 February 2004 Pages: 445 - 452

   

10. Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

    • Benoît Barrou
    • Gérard Benoît
    • Nicolas Thiounn

    Original Article 04 February 2004 Pages: 453 - 460

    

11. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B

    • Hyoung-Ran Kim
    • Hyun-Joo Park
    • Jongsun Kim

    Original Article 28 November 2003 Pages: 461 - 470

    

12. British Society for Immunology annual congress, Harrogate, UK, 2–5 December 2003

    • Graham Pawelec

    Meeting Report 20 February 2004 Pages: 471 - 472